Halstead Michael — SEC Form 4 filings

SEC reporting owner CIK 1521548. 11 Form 4 filings on record with FilingPulse; latest filed 2025-04-02.

Transaction summary — filings shown

Covers all 11 filings on record, filed 2024-01-12 to 2025-04-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Intra-Cellular Therapies, Inc. (ITCI)President1117 legs · 131,827 sh · $9,724,53738

Form 4 filings — Halstead Michael

FiledFormIssuerReported transactionsSource
2025-04-024Intra-Cellular Therapies, Inc. (ITCI)Disposition to issuer (D): 21,307 @ $132 · Disposition to issuer (D): 40,472 (derivative) · Disposition to issuer (D): 17,916 (derivative) · Disposition to issuer (D): 13,133 (derivative) · Disposition to issuer (D): 24,478 (derivative) · Disposition to issuer (D): 45,454 (derivative) · +4 moreEDGAR
2025-03-104Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 13,133 · Tax withholding (F): 6,718 @ $131.19 · Option exercise (M): 7,345 · Tax withholding (F): 3,757 @ $131.24 · Option exercise (M): 13,133 (derivative) @ $0 · Option exercise (M): 7,345 (derivative) @ $0EDGAR
2025-03-044Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 12,239 · Tax withholding (F): 6,261 @ $128.20 · Option exercise (M): 12,239 (derivative) @ $0EDGAR
2025-02-044Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 11,017 @ $0 · Tax withholding (F): 5,691 @ $127 · Grant/award (A): 45,454 (derivative) @ $0EDGAR
2024-11-144Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 22,869 @ $23.94 · Sale (S): 15,105 @ $88.72 · Sale (S): 6,116 @ $89.63 · Sale (S): 1,648 @ $90.89 · Option exercise (M): 18,714 @ $36.89 · Sale (S): 13,371 @ $88.17 · +3 moreEDGAR
2024-03-114Intra-Cellular Therapies, Inc. (ITCI)Sale (S): 12,912 @ $66.14 · Sale (S): 220 @ $66.81 · Option exercise (M): 7,345 · Sale (S): 6,107 @ $65.82 · Sale (S): 1,238 @ $66.70 · Option exercise (M): 7,345 (derivative) @ $0EDGAR
2024-03-084Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 13,132 · Option exercise (M): 13,132 (derivative) @ $0EDGAR
2024-03-054Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 36,717 (derivative) @ $0EDGAR
2024-02-274Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 7,907 · Sale (S): 300 @ $68.54 · Sale (S): 7,215 @ $69.54 · Sale (S): 392 @ $70.13 · Option exercise (M): 7,907 (derivative) @ $0EDGAR
2024-02-054Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 11,860 @ $0 · Sale (S): 11,146 @ $66.37 · Sale (S): 714 @ $67.17EDGAR
2024-01-124Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 46,115 @ $12.73 · Option exercise (M): 3,885 @ $23.94 · Sale (S): 18,154 @ $66.31 · Sale (S): 30,360 @ $67.10 · Sale (S): 1,486 @ $67.80 · Option exercise (M): 46,115 (derivative) @ $0 · +1 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1521548 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →